This allowed us to study a comprehensive panel of potential T-Ag–derived T cell epitopes, covering the full HLA ligandome and restricted to a broad range of HLA haplotypes, thereby capturing the majority of T-Ag–reactive CD8+ T cells present in the circulation of ICI-treated MCC patients to evaluate their response to therapy. Here, CD8A is linked to Merkel cell skin cancer.